An assessment of oseltamivir for the treatment of suspected influenza
Husereau DR, Brady B, McGeer A
Record ID 32002000370
English, French
Authors' objectives:
The objectives of this assessent are (1) to assess and quantify the efficacy and effectiveness of oseltamivir in individuals who are suspected of having influenza; and (2) to assess the cost-effectiveness of treating suspected influenza with oseltamivir in a primary care setting where standard treatment is no active medical intervention.
Authors' recommendations:
There is insufficient evidence that oseltamivir reduces complications, hospitalizations and/or death in individuals suspected of having influenza. In addition, there is insufficient evidence of any benefit in individuals with suspected influenza who are at risk for developing complications. Evidence from one trial suggests that otherwise healthy individuals suspected of having influenza, return to normal activity faster when treated with oseltamivir than those receiving placebo. No studies are available to compare the magnitude of this benefit to amantadine, zanamivir or symptom-relieving medications.
Authors' methods:
Systematic review, Decision-analysis model
Details
Project Status:
Completed
URL for project:
https://www.ccohta.ca/
Year Published:
2002
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Costs and Cost Analysis
- Influenza, Human
Contact
Organisation Name:
Canadian Coordinating Office for Health Technology Assessment
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553, Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Coordinating Office for Health Technology Assessment (CCOHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.